Director Shareholding
20 July 2001 - 1:28AM
UK Regulatory
RNS Number:2011H
GW Pharmaceuticals PLC
19 July 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1. Name of Company
G W Pharmaceuticals plc
2. Name of Director
Dr Brian Anthony Whittle
3. Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in
respect of a non-beneficial interest
Beneficial interest in respect of 2 above
4. Name of the registered holder(s) and, if more than one holder, the number
of shares held by each of them (if notified)
Brian Whittle Associates Limited
5. Please state whether notification relates to a person(s) connected with the
Director named in 2 above and identify the connected person(s)
As 2 above
6. Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non
discretionary
Purchase
7. Number of shares/amount of stock acquired
50,000
8. Percentage of issued class
0.052%
9. Number of shares/amount of stock disposed
N/A
10. Percentage of issued class
N/A
11. Class of security
Ordinary Shares
12. Price per share
#1.24p
13. Date of transaction
17th July 2001
14. Date company informed
19th July 2001
15. Total holding following this notification
11,545,446
16. Total percentage holding of issued class following this notification
12.02%
If a director has been granted options by the company please complete the
following boxes
17. Date of grant
18. Period during which or date on which exercisable
19. Total amount paid (if any) for grant of the option
20. Description of shares or debentures involved: class, number
21. Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise
22. Total number of shares or debentures over which options held following
this notification
23. Any additional information
24. Name of contact and telephone number for queries
Justin Gover, 01980 557 000
25. Name and signature of authorised company official responsible for making
this notification
Justin Gover, Managing Director
Date of Notification: 19th July 2001
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More GW Pharmaceuticals News Articles